The purpose of this article is to provide a critical examination of two aspects of culture and biomedicine that have helped to shape the meaning and practice of genetic testing for breast cancer. These are: (1) the cultural construction of fear of breast cancer, which has been fuelled in part by (2) the predominance of a ‘risk’ paradigm in contemporary biomedicine. The increasing elaboration and delineation of risk factors and risk numbers are in part intended to help women to contend with their fear of breast cancer. However, because there is no known cure or foolproof prevention for breast cancer, risk designations bring with them recommendations for vigilant surveillance strategies and screening guidelines. We argue that these in effect exacerbate women’s fears of breast cancer itself. The volatile combination of discourses of fear, risk and surveillance have significant ethical and social consequences for women’s lives and well-being. Genetic testing decisions are made within this context; if nurses understand this context they can play an important role in helping women to cope with the anxiety and fear of breast cancer risk.
Press N , Burke W , Durfy S.How are Jewish women different from all other women?Anthropological perspectives on genetic susceptibility testing for breast cancer . Health Matrix1997; 7: 135-162 .
2.
Burke W , Press N , Pinsky L.BRCA1 and BRCA2: a small part of the puzzle . J Natl CancerInst1999; 91: 904-905 .
3.
Koenig BA , Greely HT , McConnell LM , Silverberg HL , Raffin TA.Genetic testing for BRCA1 and BRCA2: recommendations of the Stanford Program in Genomics, Ethics, and Society Breast Cancer Working Group . J Wom Health1998; 7: 531-545 .
4.
Parens E.Glad and terrified: on the ethics of BRCA1 and 2 testing . Cancer Invest1996; 14: 405-411 .
5.
Kash KM.Psychosocial and ethical implications of defining genetic risk for cancers . Ann NY Acad Sci1995; 768: 41-52 .
6.
King MC , Rowell S , Love SM.Inherited breast and ovarian cancer: what are the risks? What are the choices?JAMA1993; 269: 1975-1980 .
7.
Croyle RT , Smith KR , Botkin JR , Baty B , Nash J.Psychological responses to BRCA1 mutation testing: preliminary findings . Health Psychol1997; 16: 63-72 .
8.
Marteau TM , Croyle RT.The new genetics. Psychological responses to genetic testing . BMJ1998; 316: 693-696 .
9.
Lerman C , Narod S , Shulman K , et al.BRCA1 testing in families with hereditary breast cancer: a prospective study of patient decision-making and outcomes . JAMA1996; 275: 1885-1892 .
10.
Watson M , Lloyd SM , Eeles R , et al.Psychosocial impact of testing (by linkage) for the BRCA1 breast cancer gene: an investigation of two families in the research setting . Psycho Oncol1996; 5: 233-239 .
11.
Dudok de Wit AC , Tibben A , Frets PG , et al.BRCA1 in the family: a case description of the psychological implications . Am J Med Genet1997; 71: 63-71 .
12.
Green RM , Thomas AM.Whose gene is it? A case discussion about familial conflict about genetic testing for breast cancer . J Genet Counsel1997; 6: 245-253 .
13.
Lerner BH.Great expectations: historical perspectives on genetic breast cancer testing . AmJ Public Health1999; 89: 938-944 .
14.
Parker LS.Breast cancer genetic screening and critical bioethics’ gaze . J Med Philos1995; 20: 313-337 .
15.
Eisinger F , Geller G , Burke W , Holtzman NA.Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer . Lancet1999; 353: 919-920 .
16.
Gordon DR , Kaplan J.Cultural context for genetic testing for breast cancer susceptibility in the US and the quest for knowledge, autonomy, and control. In: Koenig BA , Greely H , Raffin TA eds. Genetic testing for BRCA 1 and 2. Cambridge: Cambridge University Press , in press.
17.
Foucault M.The birth of the clinic: an archeology of medical perception. New York: Vintage , 1975.
18.
Foucault M.Discipline and punish. New York: Vintage , 1979.
19.
Turner BS.Medical power and social knowledge, second edition. London: Sage , 1995.
20.
Lupton D.Medicine as culture: illness, disease and the body in western society. London: Sage ,1994.
21.
Sawicki J.Disciplining Foucault: feminism, power, and the body. New York: Routledge , 1991.
22.
Radford DM , Zehnbauer BA.Inherited breast cancer . Surg Clin North Am1996; 76: 205-220 .
23.
Balsamo A.Public pregnancies and cultural narratives of surveillance. In: Clarke AE , Olesen VL eds. Revisioning women, health, and healing. New York: Routledge , 1999: 231-253.
24.
Harding J.Bodies at risk: sex, surveillance and hormone replacement therapy. In: Petersen A , Bunton R eds. Foucault, health, and medicine. London: Routledge , 1997: 134-150.
25.
Howson A.Surveillance, knowledge, and risk: the embodied experience of cervical screening . Health1998; 2: 195-215 .
26.
Marshall E.The politics of breast cancer . Science1993; 259: 616-617 .
27.
Oxenhandler N.Fruits of the body . Vogue1995: (June): 56-63 .
28.
Brody JE.Coping with fear: keeping breast cancer in perspective . New York Times1999 Oct12; D7-D7 .
29.
Smith BL , Gadd MA , Lawler C , et al.Perception of breast cancer risk among women in breast center and primary care settings: correlation with age and family history of breast cancer . Surgery1996; 120: 297-303 .
30.
Alexander NE , Ross J , Sumner W , Nease RF , Littenberg B.The effect of an educational intervention on the perceived risk of breast cancer . J Gen Intern Med1996; 11: 92-97 .
31.
Black WC , Nease RF , Tosteson AN.Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age . J Natl Cancer Inst1995; 87: 720-731 .
32.
Lerman C , Kash K , Stefanek M.Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior . J Natl Cancer Inst1994; 16: 171-176 .
33.
Laurence L.The breast cancer epidemic: women aren’t just scared, we’re mad . McCall’s1991;119(2): 24-40 .
34.
Press N.The voices of women at low and moderate risk . Proceedings of a conference on genetic testing for breast cancer susceptibility: the science, the ethics, the future; 1997 Nov 23; Stanford University Center for Biomedical Ethics Program in Genomics, Ethics and Society, Palo Alto, CA.
35.
Armstrong D.The rise of surveillance medicine . Sociol Health Illness1995; 17: 393-404 .
36.
Petersen A.Risk, governance, and the new public health. In: Petersen A , Bunton R eds. Foucault, health, and medicine. London: Routledge , 1997: 189-223.
37.
Castel R.From dangerousness to risk. In: Burchell G , Gordon C , Miller P eds. The Foucault effect. Chicago, IL: University of Chicago Press , 1991: 281-298.
38.
Lupton D.Risk as moral danger: the social and political functions of risk discourse in public health . Int J Health Serv1993; 23: 425-435 .
39.
Gail M , Brinton L , Byar Det al.Projecting individualized probabilities of developing breast cancer for white females who are being examined annually . J Natl Cancer Inst1989; 81: 1879-1886 .
40.
Claus EB , Risch N , Thompson WD.Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction . Cancer1994; 73: 643-651 .
41.
Benichou J , Gail M , Mulvihill J.Graphs to estimate an individualized risk of breast cancer . J Clin Oncol1996; 14: 103-110 .
42.
Mulvihill JJ , Stadler MP.Breast cancer risk analysis and counseling . Clin Obstet Gynecol1996;39: 851-859 .
43.
Hulka B , Stark A.Breast cancer: cause and prevention . Lancet1995; 346: 883-887 .
44.
Marshall E.Search for a killer: focus shifts from fat to hormones . Science1993, 259: 618-621 .
45.
Stoll BA.Perimenopausal weight gain and progression of breast cancer precursors . Cancer Detect Prev1999; 23: 31-36 .
46.
Smith-Warner SA , Spiegelman D , Yaun SSet al.Alcohol and breast cancer in women: a pooled analysis of cohort studies . JAMA1998; 279: 535-540 .
47.
Douglas M.Purity and danger: an analysis of concepts of pollution and taboo. Harmondsworth:Penguin , 1970.
48.
Ehrenreich B , English D.For her own good: 150 years of the experts’ advice to women. Garden City, NY: Anchor Press , 1978.
49.
Beck U.Risk society: towards a new modernity. London: Sage , 1992.
50.
Hacking I.The taming of chance. Cambridge: Cambridge University Press , 1990.
51.
Petridou E , Syrigou E , Toupadaki N , Zavitsanos X , Willett W , Trichopoulos D.Determinants of age at menarche as early life predictors of breast cancer risk . Int J Cancer1996; 68: 193-198 .
52.
Henderson M.Current approaches to breast cancer prevention . Science1993; 259: 630-631 .
53.
Koenig BA , Stockdale AS.The promise of molecular medicine in preventing disease: examining the burden of genetic risk. In: Callahan D ed. Health promotion and disease prevention: ethical and social dilemmas. Washington, DC: Georgetown University Press , in press.
54.
Jatoi I.Breast cancer screening . Am J Surg1999; 177: 518-524 .
55.
Audrain J , Rimer B , Cella Det al.The impact of a brief coping skills intervention on adherence to breast self-examination among first-degree relatives of newly diagnosed breast cancer patients . Psycho Oncol1999; 8: 220-229 .
56.
Benedict S , Goon G , Hoomani J , Holder P.Breast cancer detection by daughters of women with breast cancer . Cancer Pract1997; 5: 213-219 .
57.
Brain K , Norman P , Gray J , Mansel R.Anxiety and adherence to breast self-examination in women with a family history of breast cancer . Psychosom Med1999; 61: 181-187 .
58.
Parker LS , Majeske RA.Standards of care and ethical concerns in genetic testing and screening . Clin Obstet Gynecol1996; 39: 873-884 .
59.
Engelking C.New approaches: innovations in cancer prevention, diagnosis, treatment, and support . Oncol Nurs Forum1994; 21: 61-71 .
60.
Mahon S.Prevention and early detection of cancer in women . Semin Oncol Nurs1995; 11: 88-102 .
61.
Smith P.Familial breast and ovarian cancers . Semin Oncol Nurs1992; 8: 258-264 .
